Skip to main content
. 2017 Aug 8;8(62):104745–104760. doi: 10.18632/oncotarget.20065

Table 3. RTKs selectivity profile of the most active compounds (IC50, nM).

Compound VEGFR-1 PDGFR-β FGFR-1 FGFR-4 B-Raf EGFR c-Kit
QDAU4 68.3 >500 165.9 83.4 136 113 >500
QDAU5 192 98.5 176.2 >500 >500 98.8 142